Unirise Pharmaceuticals Private Limited
About Unirise Pharmaceuticals Private Limited
Data last updated:
Unirise Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U74900UP2013PTC060537. Its GSTIN is 09AABCU6469R1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shobha Rai and Shyam Narayan Rai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No S – 502 Silver Line Ganeshpur Rahmanpur, Lucknow, Uttar Pradesh, India – 226028.
As per the financials filed for FY 2024, the company reported a revenue of ₹40.2 Lakh, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹29,383 (net margin -0.7%) and EBITDA of ₹2.15 Lakh (EBITDA margin 5.3%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Unirise Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No S – 502 Silver Line Ganeshpur Rahmanpur, Lucknow, Uttar Pradesh, India – 226028
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Unirise Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unirise Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Unirise Pharmaceuticals Private Limited, buy the company report.
Financials of Unirise Pharmaceuticals Private Limited
FY 2025 filings availableUnirise Pharmaceuticals Private Limited reported revenue of ₹40.2 Lakh (up 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 1% growth in the latest year. EBITDA fell 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹29,383 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | -0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unirise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Unirise Pharmaceuticals Private Limited
Unirise Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shobha Rai | Director | 11 Nov 2013 | 13 Years 0 Months | Current |
| Shyam Narayan Rai | Director | 11 Nov 2013 | 13 Years 0 Months | Current |
Auditor
Unirise Pharmaceuticals Private Limited is audited by MAYANK MEHROTRA & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MAYANK MEHROTRA & ASSOCIATES | FY 2020 | 022941C |
Shareholding
The shareholding of Unirise Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Unirise Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Dec 2020 | 100414115 | State Bank of India | ₹11 Lakh | Open | |
| 30 Dec 2020 | 100442516 | Hdfc Bank Limited | ₹9 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Unirise Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unirise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unirise Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCU6469R1ZB | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unirise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Unirise Pharmaceuticals Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Richa Rai ceased to be Director on 31 Mar 2019.
Frequently asked questions
Unirise Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 November 2013 (13+ years old) and is registered under CIN U74900UP2013PTC060537.
Unirise Pharmaceuticals has 2 current directors:
- Shobha Rai - Director
- Shyam Narayan Rai - Director
The latest financial statements of Unirise Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unirise Pharmaceuticals is 09AABCU6469R1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Unirise Pharmaceuticals is U74900UP2013PTC060537. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unirise Pharmaceuticals was incorporated on 11 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Richa Rai ceased to be Director on 31 Mar 2019. Shobha Rai was appointed as Director on 11 Nov 2013. Shyam Narayan Rai was appointed as Director on 11 Nov 2013.
The registered office of Unirise Pharmaceuticals is at H.No S – 502 Silver Line Ganeshpur Rahmanpur, Lucknow, Uttar Pradesh, India – 226028.
Unirise Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Unirise Pharmaceuticals has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
